Rani Therapeutics: Co, Progen to Share Responsibilities for Rt-114, Including 50/50 Cost & Revenue Share
Rani Therapeutics:公司和保力進控股將共同承擔Rt-114的責任,包括50/50的成本和營業收入分享。
Rani Therapeutics: Co, Progen to Share Responsibilities for Rt-114, Including 50/50 Cost & Revenue Share
Rani Therapeutics:公司和保力進控股將共同承擔Rt-114的責任,包括50/50的成本和營業收入分享。
譯文內容由第三人軟體翻譯。